Robbins Farley’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $193 | Hold |
3
| – | – | ﹤0.01% | 163 |
|
|
2025
Q1 | $191 | Sell |
3
-191
| -98% | -$12.2K | ﹤0.01% | 146 |
|
|
2024
Q4 | $12.9K | Sell |
194
-95
| -33% | -$6.32K | 0.01% | 105 |
|
|
2024
Q3 | $20.2K | Buy |
289
+1
| +0.3% | +$70 | 0.01% | 95 |
|
|
2024
Q2 | $18.7K | Buy |
288
+6
| +2% | +$389 | 0.01% | 95 |
|
|
2024
Q1 | $18.3K | Sell |
282
-12
| -4% | -$777 | 0.01% | 94 |
|
|
2023
Q4 | $19.4K | Buy |
294
+44
| +18% | +$2.9K | 0.01% | 93 |
|
|
2023
Q3 | $14.3K | Buy |
250
+5
| +2% | +$285 | 0.01% | 105 |
|
|
2023
Q2 | $15K | Sell |
245
-22
| -8% | -$1.35K | 0.01% | 98 |
|
|
2023
Q1 | $16.8K | Buy |
267
+4
| +2% | +$251 | 0.01% | 98 |
|
|
2022
Q4 | $16.7K | Buy |
263
+157
| +148% | +$9.97K | 0.01% | 90 |
|
|
2022
Q3 | $6K | Sell |
106
-18
| -15% | -$1.02K | ﹤0.01% | 101 |
|
|
2022
Q2 | $7K | Buy |
124
+17
| +16% | +$960 | 0.01% | 77 |
|
|
2022
Q1 | $7K | Buy |
107
+8
| +8% | +$523 | 0.01% | 96 |
|
|
2021
Q4 | $7K | Buy |
+99
| New | +$7K | 0.01% | 101 |
|
|
2021
Q2 | – | Sell |
-95
| Closed | -$7K | – | 154 |
|
|
2021
Q1 | $7K | Buy |
95
+7
| +8% | +$516 | 0.01% | 120 |
|
|
2020
Q4 | $6K | Buy |
+88
| New | +$6K | 0.01% | 93 |
|